To explore the role of nerve growth factor receptor p75<sup>NTR</sup> during the terminal neuronal development of the mammalian cochlea the onset of hearing and the in vitro response of spiral ganglion neurites to neurotrophin 3 (NT-3), which is known to play a critical role during neonatal inner ear development, were investigated in p75<sup>NTR</sup>-deficient mice (p75<sup>NTR</sup>–/–). Auditory-evoked brain stem response recordings from p75<sup>NTR</sup>–/– and wild-type (WT) littermates were measured from postnatal days (PD) 8 to 23. Additionally, spiral ganglion explants from p75<sup>NTR</sup>–/– and WT animals were dissected and cultured in an organotypic tissue culture system. In both groups, spiral ganglion neurite outgrowth was analyzed with and without NT-3 supplementation. No significant differences in the onset of hearing of mutant mice compared to the WT mice were detected, and both groups showed a similar development of hearing until PD 23. After stimulation with NT-3, neurite outgrowth was enhanced in both p75<sup>NTR</sup>–/– and WT mice. However, neurites from p75<sup>NTR</sup>–/– spiral ganglion explants were longer in both culture conditions. Moreover, NT-3 did not significantly enhance neurite number in p75<sup>NTR</sup>–/–, as it did in WT mice. P75<sup>NTR</sup> has a remarkable influence on spiral ganglion neurite growth behavior. However, p75<sup>NTR</sup> does not seem to be essential for the development of basic hearing function in the first 3 postnatal weeks.